Received Jul 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | HA9CH | — |
Boostrix expired dose administration; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 66-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number HA9CH, expiry date 13-JUL-2025) for prophylaxis. On 21-JUL-2025, the patient received Boostrix. On 21-JUL-2025, an unknown time after receiving Boostrix, the patient experienced expired vaccine used (Verbatim: Boostrix expired dose administration). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 21-JUL-2025 The pharmacist had wanted to receive information regarding the administration of a Boostrix dose that had expired less than 30 days prior, which led to Expired vaccine used. He then inquired about the risk of administering another shot that day, so the call had been transferred to the second line